Literature DB >> 21258799

Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature.

Melissa Padovan1, Luisa Maria Caniatti, Francesco Trotta, Marcello Govoni.   

Abstract

To describe a rare association between rheumatoid arthritis (RA) and amyotrophic lateral sclerosis (ALS). Two new cases of patients with RA who developed amyotrophic lateral sclerosis (ALS), one receiving anti-TNFα agents, were reported. Only other five cases of this rare association have been previously described in literature. The simultaneous presence of the two diseases represents a difficult diagnostic challenge because RA may mimic some musculoskeletal symptoms of ALS. There is no evidence in favor of a common pathophysiologic mechanism, and thus the possibility of a fortuitous association must be raised. A neurotoxic side effect of various drugs for RA treatment could be considered. Casual or causal association remains a difficult choice. The possibility of a coincidental association must be raised but neurologic side effects of TNFα blockers lead to discussion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258799     DOI: 10.1007/s00296-010-1760-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  49 in total

1.  Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis. A puzzle illustrated by a new case.

Authors:  P M'Bappé; A Moguilevski; C Arnal; J J Cocheton; E Roullet
Journal:  Joint Bone Spine       Date:  2000       Impact factor: 4.929

2.  [de Gorgerot-Sjogren syndrome simulating amyotrophic lateral sclerosis].

Authors:  H Attout; F Rahmeh; F Ziegler
Journal:  Rev Med Interne       Date:  2000-08       Impact factor: 0.728

3.  Amyotrophic lateral sclerosis--are microglia killing motor neurons?

Authors:  David R Borchelt
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

4.  Diagnosis of amyotrophic lateral sclerosis in a patient treated with TNFalpha blockers for ankylosing spondylitis: fortuitus association or new side effect of TNFalpha blockers?

Authors:  Valentine Loustau; Violaine Foltz; Cécile Poulain; Sylvie Rozenberg; Gaëlle Bruneteau
Journal:  Joint Bone Spine       Date:  2008-10-26       Impact factor: 4.929

Review 5.  Adalimumab: a review of side effects.

Authors:  Noah Scheinfeld
Journal:  Expert Opin Drug Saf       Date:  2005-07       Impact factor: 4.250

6.  Chloroquine neuromyopathy.

Authors:  J A Hicklin
Journal:  Ann Phys Med       Date:  1968-02

7.  Neuroprotective effect of various cytokines on developing spinal motoneurons following axotomy.

Authors:  K Ikeda; Y Iwasaki; T Shiojima; M Kinoshita
Journal:  J Neurol Sci       Date:  1996-02       Impact factor: 3.181

8.  Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.

Authors:  S Raghavendra; M D Nair; T Chemmanam; T Krishnamoorthy; V V Radhakrishnan; A Kuruvilla
Journal:  Eur J Neurol       Date:  2007-03       Impact factor: 6.089

Review 9.  Biochemical and clinical aspects of methotrexate neurotoxicity.

Authors:  Sandra Vezmar; Achim Becker; Udo Bode; Ulrich Jaehde
Journal:  Chemotherapy       Date:  2003-05       Impact factor: 2.544

10.  Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.

Authors:  P Andreas Jonsson; Karin Ernhill; Peter M Andersen; Daniel Bergemalm; Thomas Brännström; Ole Gredal; Peter Nilsson; Stefan L Marklund
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

View more
  6 in total

Review 1.  Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature.

Authors:  Rikitha Menezes; Alexander Pantelyat; Izlem Izbudak; Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

Review 2.  Amyotrophic Lateral Sclerosis, a Multisystem Pathology: Insights into the Role of TNFα.

Authors:  Massimo Tortarolo; Daniele Lo Coco; Pietro Veglianese; Antonio Vallarola; Maria Teresa Giordana; Gabriella Marcon; Ettore Beghi; Marco Poloni; Michael J Strong; Anand M Iyer; Eleonora Aronica; Caterina Bendotti
Journal:  Mediators Inflamm       Date:  2017-09-10       Impact factor: 4.711

3.  Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases.

Authors:  Jin-Yue Li; Xiao-Han Sun; Dong-Chao Shen; Xun-Zhe Yang; Ming-Sheng Liu; Li-Ying Cui
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

Review 4.  Motor neuron disease in a patient with overlap syndrome (rheumatoid arthritis; systemic lupus erythematosus, Sjogren's syndrome).

Authors:  Ebru Atalar; Fatma Gül Yurdakul; Kevser Gök; Tuba Güler; Şükran Erten; Evren Yaşar; Hatice Bodur
Journal:  Rheumatol Int       Date:  2022-09-18       Impact factor: 3.580

5.  Is there a link between amyotrophic lateral sclerosis and treatment with TNF-alpha inhibitors?

Authors:  A Börjesson; B Grundmark; H Olaisson; L Waldenlind
Journal:  Ups J Med Sci       Date:  2013-04-08       Impact factor: 2.384

Review 6.  Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials.

Authors:  Syed I Khalid; Leonel Ampie; Ryan Kelly; Shafeeq S Ladha; Christopher Dardis
Journal:  Front Neurol       Date:  2017-09-25       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.